Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Symphony Environmental Technologies Plc LSE:SYM London Ordinary Share GB0009589168 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.50 -2.67% 18.25 18.00 18.50 18.75 18.25 18.75 269,846 10:35:12
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Chemicals 9.8 -0.4 -0.2 - 32

Symphony Environmental T... Share Discussion Threads

Showing 6351 to 6374 of 6925 messages
Chat Pages: Latest  265  264  263  262  261  260  259  258  257  256  255  254  Older
DateSubjectAuthorDiscuss
27/4/2020
10:22
How about succinct summary OP? Cannot access your link. thanks in advance if doable
chinadog3
27/4/2020
09:10
https://www.thetimes.co.uk/article/hail-the-plastic-maker-our-heroes-true-hero-7zrj9s8hf?shareToken=facefe20025ee53377eb897964493b5eHow long before they come to SYM? The answer is here.
optimistic punter
17/4/2020
15:38
tis the end of the week Phil - where is my 20p?. They could not sell PPE in a Corona epidemic this lot - woeful
swiss paul
15/4/2020
10:45
You may be right PJ
chinadog3
14/4/2020
18:21
Back up to 20p by end of the week. Totally unique business and fantastic opportunity.
philjeans
14/4/2020
18:14
6th April TS Based on current financial modelling, the Group does not expect to need any additional cash in the next 12 months and will be able to continue to operate within its current financial resources.
replicas1967
14/4/2020
17:54
Placing at 50 p👍
gemlotte55
14/4/2020
16:55
When's the placing?
bbmsionlypostafter
14/4/2020
16:38
www.symphonyenvironmental.com Symphony has developed a range of additives, concentrates and master-batches marketed under its d2p(R) ("designed to protect") trademark, which can be incorporated in a wide variety of plastic and non-plastic products so as to provide protection against many different types of microbes, and insects and rodents, and against fire. d2p products also include odour, moisture and ethylene adsorbers as well as other types of food-preserving technologies. Symphony has also launched d2p anti-microbial household gloves and toothbrushes and is developing a range of other d2p finished products for retail sale. See www.d2p.net Symphony has developed and continues to develop, a biodegradable plastic technology which helps tackle the problem of microplastics by turning ordinary plastic at the end of its service-life into biodegradable materials. It is then no longer a plastic and can be bioassimilated in the open environment in a similar way to a leaf. The technology is branded d2w(R) and appears as a droplet logo on many thousands of tonnes of plastic packaging and other plastic products around the world. In some countries, most recently Saudi Arabia, oxo-biodegradable plastic is mandatory. See www.d2w.net The Group has complemented its d2w biodegradable product range with d2c "compostable resins and products" that have been tested to US and EU composting standards. Symphony has also developed the d2Detector(R), a portable device which analyses plastics and detects counterfeit products. This is useful to government officials tasked with enforcing legislation, and Symphony's d2t tagging and tracer technology is available for further security. Symphony has a diverse and growing customer-base and has established itself as an international business with 74 distributors around the world. Products made with Symphony's plastic technologies are now available in nearly 100 countries and in many different product applications. Symphony itself is accredited to ISO9001 and ISO14001.
philjeans
14/4/2020
16:17
Fair enough KK ;-) glad you guys u-turned on furloughing! Agreed, and like I said, I really don’t know what I was waiting for! 25 years in, it feels like the time is now, and I don’t just mean the Covid factor. Supermarkets order books have gone crazy of the back of the current pandemonium which must be good for orders from SYM too. Once the contagion is through then we’ve still got so much to be positive about with their suite of products GLA D
dennisbergkamp
14/4/2020
13:07
Dennis, I'll let you have the name (being a Spuds fan) 😜 Digressing, it's not too late as if they start to get major contracts (esp after the FDA approval): "Enquiries for our d2p (designed to protect) anti-microbial and other protective products (see www.d2p.net) are growing at a much faster pace and we expect to see increased sales as additional protection becomes an everyday necessity. " Also, if the D2P proves effective against COVID19 then can you imagine where this will rocket to..... "On 10 March 2020, we announced that we had initiated independent testing of our d2p anti-microbial technology against members of the Coronavirus group, with results expected before the end of June. We can advise, based on scientific literature and research, that the active ingredient used by Symphony does have good anti-viral properties, and the tests will ascertain performance within general plastic products with d2p included. Satisfactory test results would enable d2p treated products to be sold to a wider market, and we will test against COVID-19 itself as soon as independent laboratory capacity becomes available."
k1ngkonggb
14/4/2020
13:06
Last week; The new trading year has started strongly, with revenues for the first quarter ended 31 March 2020 increasing 56% to GBP2.4 million compared with GBP1.6 million for the first quarter of 2019. The Group's cash position at 31 March 2020 was relatively healthy with more than GBP1.0 million available between cash and existing bank facilities. Based on current financial modelling, the Group does not expect to need any additional cash in the next 12 months and will be able to continue to operate within its current financial resources. In the Group's trading update on 17 December 2019, we reported on inventory adjustments by some of our customers awaiting legislative clarification in certain markets which depressed sales in the final quarter of 2019 with an expectation that these sales would be deferred into the first quarter of 2020. In the majority of these markets, inventory levels have so far remained low. Therefore, whilst this first quarter revenue does not include any material inventory correction, we continue to expect inventory levels in our network to increase during the year. The increase in revenue for the first quarter of 2020 is therefore a more general reflection of the organic growth achieved by our distribution network. As the impact of the COVID 19 pandemic is felt across the globe, the Group has taken, and continues to take all necessary measures to ensure that our workplace, people and customers are safeguarded and that we have protocols and technology in place for business continuity by remote working. The Group had seen limited effects in some supply-chain areas which have to date been quickly overcome and not resulted in any raw material or manufacturing delays. Some customers have reported cashflow delays within their territories. Our trade receivables are, in the main, credit insured, and our credit insurer has granted an extension of reporting deadlines in order to assist. Enquiries for our d2p (designed to protect) anti-microbial and other protective products (see www.d2p.net ) are growing at a much faster pace and we expect to see increased sales as additional protection becomes an everyday necessity. On 10 March 2020, we announced that we had initiated independent testing of our d2p anti-microbial technology against members of the Coronavirus group, with results expected before the end of June. We can advise, based on scientific literature and research, that the active ingredient used by Symphony does have good anti-viral properties, and the tests will ascertain performance within general plastic products with d2p included. Satisfactory test results would enable d2p treated products to be sold to a wider market, and we will test against COVID-19 itself as soon as independent laboratory capacity becomes available. As reported on 28 February 2020, the Food and Drug Administration (FDA) in the United States approved our anti-bacterial bread-packaging, and this is now on their official website. Some customer trials have already begun, and others are at the planning stage, albeit we acknowledge that COVID-19 may extend trial timetables. The current situation due to COVID-19 is unprecedented and the overall economic impact is currently unknown. While the Board is encouraged by the resilience shown by the Group and its employees to date, the impact on FY-2020 cannot as yet be fully assessed. Accordingly, the Board believes it would be inappropriate to provide forward looking financial guidance to investors and analysts at this time. The Board remains confident that the Group is in a strong financial position and is, with its suite of highly relevant technologies, well placed in the current environment. We anticipate announcing our 2019 preliminary results by 30 April and we will update the market further at that time. Michael Laurier, CEO of Symphony commented: "This week marks the 25(th) anniversary of the formation of the Symphony Group. The Group's suite of technologies has evolved and improved over this considerable period and their global relevance has never been more important, given the enormous impact of the COVID-19 pandemic on the lives of so many people across the globe. Our technologies provide the ability to protect lives through our anti-microbial d2p products and also help preserve our planet through our d2w oxo-biodegradable products which reduce the impact of plastics on the environment. We would like to thank our customers, shareholders, distributors and staff for all their support during our 25-year development."
philjeans
14/4/2020
12:59
Jumped on but sooo late. Been watching this for sooo long. Don’t even know why I didn’t earlier.. D
dennisbergkamp
14/4/2020
12:56
Yes - going very much higher. Been developing safe products for years - now right place/right time. STRONG BUY.
philjeans
14/4/2020
12:30
Re-test of 20p coming here? Big buying this morning & very cheap at £20m market cap considering they have FDA approval & plenty of other news in the pipeline. (Ignore Dave4545 who clearly has no idea how to value a business...)
74tom
14/4/2020
11:57
hTTps://www.proactiveinvestors.co.uk/companies/news/916847/symphony-environmental-technologies-plc-has-seen-demand-for-anti-microbial-products-soar-says-ceo-916847.html Has everyone missed this?
74tom
10/4/2020
19:41
Mick. you obviuosly not done your homewrork on this serial disappointer
swiss paul
09/4/2020
20:39
FDA approval is huge
mick sturbs
09/4/2020
20:39
potential 10 bagger here. Massive upside. Only reason this tanked was covid19 panic. Bargain.
mick sturbs
06/4/2020
08:54
Dave, you could do alot worse....Bagir...eh!!!!!
k1ngkonggb
06/4/2020
08:45
20 mil cap 1 mil cash and people are chasing this up on that update ? blimey nice for some
dave4545
06/4/2020
08:42
12.70 paid, this is going to pop!
natty27
06/4/2020
08:25
V good update and Jewel in my view is d2p has anti viral quality
chinadog3
06/4/2020
08:20
More inventory init
buywell3
Chat Pages: Latest  265  264  263  262  261  260  259  258  257  256  255  254  Older
ADVFN Advertorial
Your Recent History
LSE
SYM
Symphony E..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210621 23:20:44